Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06106698

Washed Microbiota Transplantation for Clostridioides Difficile Infection

Washed Microbiota Transplantation for Clostridioides Difficile Infection: a Real World Research

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
The Second Hospital of Nanjing Medical University · Academic / Other
Sex
All
Age
3 Years – 100 Years
Healthy volunteers
Not accepted

Summary

This is a real-world study to explore the safety and the efficacy of washed microbiota transplantation (WMT) for patients with Clostridioides Difficile Infection (CDI).

Detailed description

At least 12 subjects who meet all the inclusion criteria but do not meet any exclusion criteria will be enrolled in this study. Data of demographic characteristics, intestinal symptoms, medicine treatment usage and clinical outcomes will be collected. After treatment, they will enter the follow-up period (at least for 4-week post-WMT)for safety and efficacy evaluation. Subjects with no response and recurrence will receive salvage therapy, and the extended follow-up period will be performed.

Conditions

Interventions

TypeNameDescription
OTHERWMTWashed microbiota transplantation refers to the infusion of washed microbiota from healthy donor into patients' gastrointestinal tract. Participants will receive one dose of WMT for CDI. During follow-up, those who have non-response or CDI recurrence within 4-week post-WMT will receive rescue WMT.

Timeline

Start date
2023-07-22
Primary completion
2029-07-01
Completion
2029-12-01
First posted
2023-10-30
Last updated
2023-10-30

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06106698. Inclusion in this directory is not an endorsement.